GBP16.03 - GBP19.76 per hour: SRG: Job Title:Senior Experimentalist Location:Bracknell, Berkshire Pay Rate:Up to £19.76 an hour (circa £37,000 per annum) Contract:2 Years Bracknell, England

Funding Opportunity PAR-21-139 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites qualified academic institutions to apply for funding to modernize existing or construct new biomedical research facilities. Applications will be accepted from public and nonprofit private institutions of higher education. Applications from both research-intensive institutions and Institutions of Emerging Excellence in biomedical research from all geographic regions in the nation are strongly encouraged. NIH recognizes the importance of all institutions of higher learning in contributing to the nations research capacity. The goal of this FOA is to upgrade or create novel biomedical research infrastructure to strengthen biomedical research programs. Each project is expected to provide long-term improvements to the institutional research infrastructure. Targeted projects are the modernization of core facilities and the development of other infrastructure serving an institution-wide research community on a shared basis.

up to £45,000: CK Group: CK Group is recruiting for a Translational Bioinformatics Scientist to join a leading biopharmaceutical business who are actively trying to improve the health of patients... Slough

Interested candidates should contact Emily Garner at emily.garner@mail.wvu.edu. Ideal candidates should be strongly self-motivated and able to work well in a…
From Association of Environmental Engineering and Science Professors - Mon, 18 Jan 2021 21:08:53 GMT - View all West Virginia jobs

Competitive Salary: F. Hoffmann-La Roche AG: At Roche we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate about trans Switzerland (CH)

GBP25000.00 - GBP33000.00 per annum + Bonus + Benefits: SRG: A lab based role for an experienced molecular biologist looking to make an impact in the IVD diagnostic detection of cancer. London, England

Competitive Salary: F. Hoffmann-La Roche AG: At Roche, we believe it’s urgent to deliver medical solutions right now – even as we develop innovations for the future. We are passionate abou Switzerland (CH)

Notice NOT-NS-21-024 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-21-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support applications aimed at: (1) determining whether microbial pathogens represent a causal component ?of Alzheimers disease (AD), (2) establishing mechanisms by which microbial pathogens impact neurodegenerative processes in AD, and (3) informing aspects of future translational studies in AD, including the discovery of candidate therapeutics aimed at regulating pathogen-associated networks and molecules in AD.

Notice NOT-CA-21-030 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-001 from the NIH Guide for Grants and Contracts

Experience with analyzing and reporting data using Microsoft Office and statistical and bioinformatics programs such as Prism Graph Pad and Ingenuity Pathway…
From Perfectus Biomed - Fri, 15 Jan 2021 12:41:34 GMT - View all Jackson, WY jobs

Competitive Salary: EMBL: Software developer Location: EMB Cambridge, Cambridgeshire, England

Competitive Salary: EMBL: Helpdesk Bioinformatician - European Genome-phenome Archive Cambridge, Cambridgeshire, England

Funding Opportunity RFA-TR-21-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for multi-disciplinary diagnostic strategies for rare diseases that combine machine-assistance, genomic analysis, and clinical consultation. Of particular importance, these strategies must be able to be adopted and performed at the primary or secondary care levels by front-line healthcare providers and be readily integrated into their clinical care workflow.

Funding Opportunity RFA-EY-21-001 from the NIH Guide for Grants and Contracts. A central goal of the BRAIN Initiative is to understand how electrical and chemical signals code information in neural circuits and give rise to sensations, thoughts, emotions and actions. While currently available technologies can provide some understanding, they may not be sufficient to accomplish this goal. For example, non-invasive technologies are low resolution and/or provide indirect measures such as blood flow, which are imprecise; invasive technologies can provide information at the level of single neurons producing the fundamental biophysical signals, but they can only be applied to tens or hundreds of neurons, out of a total number in the human brain estimated at 85 billion. Other BRAIN FOAs seek to develop novel technology (RFA-NS-17-003) or to optimize existing technology ready for in-vivo proof-of-concept testing and collection of preliminary data (RFA-NS-17-004) for recording or manipulating neural activity on a scale that is beyond what is currently possible. This FOA seeks applications for unique and innovative technologies that are in an even earlier stage of development than that sought in other FOAs, including new and untested ideas that are in the initial stages of conceptualization. In addition to experimental approaches, the support provided under this FOA might enable calculations, simulations, computational models, or other mathematical techniques for demonstrating that the signal sources and/or measurement technologies are theoretically capable of meeting the demands of large-scale recording or manipulation of circuit activity in humans or in animal models. The support might also be used for building and testing phantoms, prototypes, in-vitro or other bench-top models in order to validate underlying theoretical assumptions in preparation for future FOAs aimed at testing in animal models.

Funding Opportunity PAR-21-118 from the NIH Guide for Grants and Contracts. The objective of this funding opportunity is to support investigator-initiated, phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. The proposed trial can be single or multisite. Applicants applying for funding under this FOA should be ready to initiate the clinical trial within the first quarter of the project period. Discussion, submission, and attainment of applicable regulatory (FDA, DSMB, IRB) approvals, and establishment of drug (and placebo, if applicable) supplies, and any necessary third-party agreements should be established by the time of award. If time and support for these and other pre-clinical and/or trial readiness activities are desired, applicants should consider the companion FOA which utilizes an R61/R33 phased approach.

Funding Opportunity PAR-21-119 from the NIH Guide for Grants and Contracts. The objective of this funding opportunity is to support investigator-initiated, Phase I clinical trials for diagnostic and therapeutic interventions for heart, lung, blood, and sleep (HLBS) disorders in adults and children. In addition to supporting clinical trial start-up and implementation activities, this FOA will provide support for final stage preclinical activities needed for the implementation of the proposed trial. All the activities proposed in the R61 phase must be directly related to the therapeutic/diagnostic in preparation for the clinical trial. The proposed trial can be single or multisite. This FOA will utilize a bi-phasic, milestone-driven mechanism of award where the first phase can be used to finalize required pre-trial activities such as stability, shipping studies, and site training.

Funding Opportunity PAR-21-108 from the NIH Guide for Grants and Contracts. The purpose of the NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00) is to provide support and mentorship to outstanding students enrolled in integrated dual degree dental (DDS/DMD) and PhD programs over the transition from predoctoral student to postdoctoral scholar. This phased award program will facilitate completion of predoctoral dual degree dentist scientist training (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00). It is anticipated that successful completion of this phased award program will enable dentist scientists to progress in their research careers. This Funding Opportunity Announcement (FOA) does not allow prospective fellows to propose to lead an independent clinical trial, but does allow prospective fellows to propose research experience in a clinical trial led by a sponsor or co-sponsor.